International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted)

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2019 - Volume 23, Number 5
View All Articles in Issue

Page(s): 409

Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted) Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted). Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, omeprazole, formulation, proton pump inhibitor, hyperacidity, gastric acid, stability

Related Categories: FORMULATIONS, GASTROENTEROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted) Allen Loyd V Jr	Sep/Oct 2019 Pg. 409
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) Whaley Paul A, Voudrie Mark A II, Sorenson Bridget	Mar/Apr 2012 Pg. 164-166
Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid Allen Loyd V Jr	Jan/Feb 2019 Pg. 58
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Corsini Lindsay, Williams LaVonn A	Mar/Apr 2011 Pg. 124-128
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G	Nov/Dec 2019 Pg. 504-510
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren	Mar/Apr 2020 Pg. 140-147
To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Chuong Monica C, Taglieri Catherine A, Kerr Stephen G	Nov/Dec 2017 Pg. 500-512
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Stability of Omeprazole Extemporaneous Oral Solution in Chopin Base Spennacchio Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio	May/Jun 2023 Pg. 250-255
Omeprazole 2-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2006 Pg. 389
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding Garg Sanjay, Svirskis Darren, Al-Kabban Majid, Farhan Samer, Komeshi Mohammed, Lee Jacky, Liu Quincy, Naidoo Sacha, Kairuz Therese	May/Jun 2009 Pg. 250-253
Acidifying Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 1999 Pg. 309-310
Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry Allen Loyd V Jr	Jul/Aug 2018 Pg. 321
Ranitidine 15 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2018 Pg. 56
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 148
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2019 Pg. 491
Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 493
Return to Top